BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 32940418)

  • 1. Ten year follow-up of high-risk patients treated during the early experience with transcatheter aortic valve replacement.
    Sathananthan J; Lauck S; Polderman J; Yu M; Stephenson A; Sathananthan G; Moss R; Cheung A; Ye J; Blanke P; Leipsic J; Wood DA; Webb JG
    Catheter Cardiovasc Interv; 2021 Feb; 97(3):E431-E437. PubMed ID: 32940418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Long-Term Structural Deterioration of Transcatheter Aortic Bioprosthetic Valves Using the New European Definition.
    Durand E; Sokoloff A; Urena-Alcazar M; Chevalier B; Chassaing S; Didier R; Tron C; Litzler PY; Bouleti C; Himbert D; Hovasse T; Bar O; Avinée G; Iung B; Blanchard D; Gilard M; Cribier A; Lefevre T; Eltchaninoff H
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007597. PubMed ID: 30998397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves: Results From the CHOICE Randomized Clinical Trial.
    Abdel-Wahab M; Landt M; Neumann FJ; Massberg S; Frerker C; Kurz T; Kaur J; Toelg R; Sachse S; Jochheim D; Schäfer U; El-Mawardy M; Robinson DR; Richardt G;
    JACC Cardiovasc Interv; 2020 May; 13(9):1071-1082. PubMed ID: 32305398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioprosthetic Valve Performance After Transcatheter Aortic Valve Replacement With Self-Expanding Versus Balloon-Expandable Valves in Large Versus Small Aortic Valve Annuli: Insights From the CHOICE Trial and the CHOICE-Extend Registry.
    Abdelghani M; Mankerious N; Allali A; Landt M; Kaur J; Sulimov DS; Merten C; Sachse S; Mehilli J; Neumann FJ; Frerker C; Kurz T; El-Mawardy M; Richardt G; Abdel-Wahab M
    JACC Cardiovasc Interv; 2018 Dec; 11(24):2507-2518. PubMed ID: 30503595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of structural valve deterioration and bioprosthetic valve failure utilizing the new European consensus definition in patients undergoing TAVI with first-generation devices: Outcomes beyond 5 years from a single center in Turkey.
    Şentürk B; Dursun H; Çöllüoğlu T; Özdamar H; Ekin T; Tanrıverdi Z; Kaya D
    Anatol J Cardiol; 2021 Aug; 25(8):579-587. PubMed ID: 34369886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial.
    Pibarot P; Ternacle J; Jaber WA; Salaun E; Dahou A; Asch FM; Weissman NJ; Rodriguez L; Xu K; Annabi MS; Guzzetti E; Beaudoin J; Bernier M; Leipsic J; Blanke P; Clavel MA; Rogers E; Alu MC; Douglas PS; Makkar R; Miller DC; Kapadia SR; Mack MJ; Webb JG; Kodali SK; Smith CR; Herrmann HC; Thourani VH; Leon MB; Hahn RT;
    J Am Coll Cardiol; 2020 Oct; 76(16):1830-1843. PubMed ID: 33059828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk.
    Søndergaard L; Ihlemann N; Capodanno D; Jørgensen TH; Nissen H; Kjeldsen BJ; Chang Y; Steinbrüchel DA; Olsen PS; Petronio AS; Thyregod HGH
    J Am Coll Cardiol; 2019 Feb; 73(5):546-553. PubMed ID: 30732707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes After Transcatheter Aortic Valve-in-Valve Replacement.
    de Freitas Campos Guimarães L; Urena M; Wijeysundera HC; Munoz-Garcia A; Serra V; Benitez LM; Auffret V; Cheema AN; Amat-Santos IJ; Fisher Q; Himbert D; Garcia Del Blanco B; Dager A; Le Breton H; Paradis JM; Dumont E; Pibarot P; Rodés-Cabau J
    Circ Cardiovasc Interv; 2018 Sep; 11(9):e007038. PubMed ID: 30354588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durability and Clinical Outcomes of Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses.
    Dauerman HL; Deeb GM; O'Hair DP; Waksman R; Yakubov SJ; Kleiman NS; Chetcuti SJ; Hermiller JB; Bajwa T; Khabbaz K; de Marchena E; Salerno T; Dries-Devlin JL; Li S; Popma JJ; Reardon MJ
    Circ Cardiovasc Interv; 2019 Oct; 12(10):e008155. PubMed ID: 31607151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis.
    Testa L; Latib A; Brambilla N; De Marco F; Fiorina C; Adamo M; Giannini C; Angelillis M; Barbanti M; Sgroi C; Poli A; Ferrara E; Bruschi G; Russo CF; Matteo M; De Felice F; Musto C; Curello S; Colombo A; Tamburino C; Petronio AS; Bedogni F
    Eur Heart J; 2020 May; 41(20):1876-1886. PubMed ID: 31904800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic comparison of CoreValve and SAPIEN-XT TAVI valves in Japanese patients.
    Shishido K; Yamanaka F; Ochiai T; Yamabe T; Noguchi K; Ota T; Koide Y; Ogino H; Tanaka Y; Saito S
    Heart Vessels; 2019 Oct; 34(10):1674-1683. PubMed ID: 30993441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
    Thyregod HGH; Jørgensen TH; Ihlemann N; Steinbrüchel DA; Nissen H; Kjeldsen BJ; Petursson P; De Backer O; Olsen PS; Søndergaard L
    Eur Heart J; 2024 Apr; 45(13):1116-1124. PubMed ID: 38321820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioprosthetic Valve Fracture Improves the Hemodynamic Results of Valve-in-Valve Transcatheter Aortic Valve Replacement.
    Chhatriwalla AK; Allen KB; Saxon JT; Cohen DJ; Aggarwal S; Hart AJ; Baron SJ; Dvir D; Borkon AM
    Circ Cardiovasc Interv; 2017 Jul; 10(7):. PubMed ID: 28698291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Echocardiographic Follow-Up After Transcatheter Aortic Valve Implantation to Assess Structural Valve Deterioration and Bioprosthetic Valve Failure.
    Giudicatti L; Chieng D; Ireland K; Hillis G; Sanfilippo FM; Yong G
    Heart Lung Circ; 2022 Apr; 31(4):559-565. PubMed ID: 34916154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of prosthesis-iteration evolution and sizing practice on the incidence of prosthesis-patient mismatch after transcatheter aortic valve replacement.
    Abdelghani M; Allali A; Kaur J; Hemetsberger R; Mehilli J; Neumann FJ; Frerker C; Kurz T; El-Mawardy M; Richardt G; Abdel-Wahab M
    Catheter Cardiovasc Interv; 2019 Apr; 93(5):971-979. PubMed ID: 30467966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure.
    Barbanti M; Webb JG; Tamburino C; Van Mieghem NM; Makkar RR; Piazza N; Latib A; Sinning JM; Won-Keun K; Bleiziffer S; Bedogni F; Kapadia S; Tchetche D; Rodés-Cabau J; Fiorina C; Nombela-Franco L; De Marco F; de Jaegere PP; Chakravarty T; Vaquerizo B; Colombo A; Svensson L; Lange R; Nickenig G; Möllmann H; Walther T; Della Rosa F; Elhmidi Y; Dvir D; Brambilla N; Immè S; Sgroi C; Gulino S; Todaro D; Pilato G; Petronio AS; Tamburino C
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term durability of self-expanding and balloon-expandable transcatheter aortic valve prostheses: UK TAVI registry.
    Ali N; Hildick-Smith D; Parker J; Malkin CJ; Cunnington MS; Gurung S; Mailey J; MacCarthy PA; Bharucha A; Brecker SJ; Hoole SP; Dorman S; Doshi SN; Wiper A; Buch MH; Banning AP; Spence MS; Blackman DJ
    Catheter Cardiovasc Interv; 2023 Apr; 101(5):932-942. PubMed ID: 36924015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcomes and Valve Performance in Patients Undergoing Transcatheter Aortic Valve Implantation.
    Stathogiannis K; Synetos A; Latsios G; Karanasos A; Trantalis G; Toskas P; Drakopoulou M; Xanthopoulou M; Karmpalioti M; Simopoulou C; Soulaidopoulos S; Oikonomou G; Benetos G; Tsalamandris S; Kosmas I; Voudris V; Mastrokostopoulos A; Katsimagklis G; Halvatsiotis P; Deftereos S; Tsioufis C; Toutouzas K
    Am J Cardiol; 2021 May; 147():80-87. PubMed ID: 33621524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic Outcome and Valve Durability Beyond Five Years After Transcatheter Aortic Valve Replacement.
    Murray MI; Hofmann E; De Rosa R; Mas-Peiro S; Seppelt P; Walther T; Zeiher AM; Fichtlscherer S; Vasa-Nicotera M
    J Invasive Cardiol; 2020 Mar; 32(3):82-87. PubMed ID: 32123140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition.
    Eltchaninoff H; Durand E; Avinée G; Tron C; Litzler PY; Bauer F; Dacher JN; Werhlin C; Bouhzam N; Bettinger N; Candolfi P; Cribier A
    EuroIntervention; 2018 Jun; 14(3):e264-e271. PubMed ID: 29599103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.